& Gold, M
But this strategy could subject Hims to risk of enforcement by the FDA and legal action from Novo, which has already filed over 60 lawsuits against firms unlawfully marketing semaglutide products and vowed to keep pursuing legal action against other entities engaged in similar conduct. When asked about its customized compounding approach, Hims directed Hunterbrook to information on its website about personalized healthcare, including an October white paper on the topic and a blog post highlighting their customers results with personalized weight loss products, as well as the Hims shareholder letter from Q3 2024
Compare provider-reviewed options Research Snapshot Provider review Regulatory status, labels, trial records, and sponsor updates can change quickly for obesity-drug pipeline pages
Absorption and Bioavailability While both forms contain the same active molecule, injectable formulations generally have higher bioavailability since they enter the bloodstream directly, potentially giving them a slight edge in weight-loss magnitude
In Florida, semaglutide injections can be given by professionals with the titles MD, DO, NP, PA, RN, LPN, or medical assistant (under supervision)